A comparative study on the clinical effects of silodosin and naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

Trial Profile

A comparative study on the clinical effects of silodosin and naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2013

At a glance

  • Drugs Silodosin (Primary) ; Naftopidil
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 19 Oct 2012 Interim results for 121 patients presented at the 42nd Annual Meeting of the International Continence Society.
    • 04 Jul 2012 Actual initiation date (Feb 2007), planned patient number (200), additional lead trial centres and investigator added and official title amended as reported by University Hospital Medical Information Network - Japan.
    • 04 Jul 2012 New source identified and integrated (University Hospital Medical Information Network - Japan, UMIN000008331).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top